Literature DB >> 12044898

Glucosamine-6-phosphate synthase--the multi-facets enzyme.

Sławomir Milewski1.   

Abstract

L-Glutamine: D-fructose-6-phosphate amidotransferase, known under trivial name of glucosamine-6-phosphate synthase, as the only member of the amidotransferase subfamily of enzymes, does not display any ammonia-dependent activity. This enzyme, catalysing the first committed step in a pathway leading to the eventual formation of uridine 5'-diphospho-N-acetyl-D-glucosamine (UDP-GlcNAc), is an important point of metabolic control in biosynthesis of amino sugar-containing macromolecules. The molecular mechanism of reaction catalysed by GlcN-6-P synthase is complex and involves both amino transfer and sugar isomerisation. Substantial alterations to the enzyme structure and properties have been detected in different neoplastic tissues. GlcN-6-P synthase is inflicted in phenomenon of hexosamine-induced insulin resistance in diabetes. Finally, this enzyme has been proposed as a promising target in antifungal chemotherapy. Most of these issues, especially their molecular aspects, have been extensively studied in recent years. This article provides a comprehensive overview of the present knowledge on this multi-facets enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044898     DOI: 10.1016/s0167-4838(02)00318-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  77 in total

1.  Protonation states of the key active site residues and structural dynamics of the glmS riboswitch as revealed by molecular dynamics.

Authors:  Pavel Banás; Nils G Walter; Jirí Sponer; Michal Otyepka
Journal:  J Phys Chem B       Date:  2010-07-08       Impact factor: 2.991

2.  An active-site guanine participates in glmS ribozyme catalysis in its protonated state.

Authors:  Júlia Viladoms; Lincoln G Scott; Martha J Fedor
Journal:  J Am Chem Soc       Date:  2011-10-20       Impact factor: 15.419

3.  Use of a coenzyme by the glmS ribozyme-riboswitch suggests primordial expansion of RNA chemistry by small molecules.

Authors:  Adrian R Ferré-D'Amaré
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-27       Impact factor: 6.237

4.  High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection.

Authors:  Jeroen De Smet; Michael Zimmermann; Maria Kogadeeva; Pieter-Jan Ceyssens; Wesley Vermaelen; Bob Blasdel; Ho Bin Jang; Uwe Sauer; Rob Lavigne
Journal:  ISME J       Date:  2016-02-16       Impact factor: 10.302

5.  Glutathione degradation by the alternative pathway (DUG pathway) in Saccharomyces cerevisiae is initiated by (Dug2p-Dug3p)2 complex, a novel glutamine amidotransferase (GATase) enzyme acting on glutathione.

Authors:  Hardeep Kaur; Dwaipayan Ganguli; Anand K Bachhawat
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

6.  Identification of glucoselysine-6-phosphate deglycase, an enzyme involved in the metabolism of the fructation product glucoselysine.

Authors:  Elsa Wiame; Pedro Lamosa; Helena Santos; Emile Van Schaftingen
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

7.  A pseudoknot in the 3' non-core region of the glmS ribozyme enhances self-cleavage activity.

Authors:  Sara R Wilkinson; Michael D Been
Journal:  RNA       Date:  2005-12       Impact factor: 4.942

8.  Mechanism and distribution of glmS ribozymes.

Authors:  Phillip J McCown; Wade C Winkler; Ronald R Breaker
Journal:  Methods Mol Biol       Date:  2012

9.  Crystallization and preliminary X-ray analysis of the isomerase domain of glucosamine-6-phosphate synthase from Candida albicans.

Authors:  Jaroslaw Olchowy; Robert Jedrzejczak; Slawomir Milewski; Wojciech Rypniewski
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-10-20

10.  Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.

Authors:  Maytham Hussein; Mei-Ling Han; Yan Zhu; Qi Zhou; Yu-Wei Lin; Robert E W Hancock; Daniel Hoyer; Darren J Creek; Jian Li; Tony Velkov
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.